scispace - formally typeset
Journal ArticleDOI

Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.

Reads0
Chats0
TLDR
The working group has revised the guidelines regarding prediction of invasive carcinoma and high-grade dysplasia, surveillance, and postoperative follow-up of IPMN and includes updated information and recommendations based on the current understanding.
About
This article is published in Pancreatology.The article was published on 2017-09-01. It has received 1104 citations till now.

read more

Citations
More filters
Journal ArticleDOI

The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made?

TL;DR: This paper is to provide a summary of how accurate the authors are currently with the identification of high-grade dysplasia or progression to carcinoma in patients who present with IPMN.
Journal ArticleDOI

Subtyping of intraductal papillary mucinous neoplasms - pitfalls of MUC1 immunohistochemistry.

TL;DR: A revision of the WHO Classification of Tumors of the Digestive System is proposed, specifying that antibodies against tumor associated MUC1 should be used for IPMN subtyping.
Journal ArticleDOI

New onset diabetes predicts progression of low risk pancreatic mucinous cysts.

TL;DR: Findings support regular diabetes screening among patients surveilled for suspected IPMNs or MCNs and new onset diabetes may predict progression in patients with low risk mucinous cysts.
Journal ArticleDOI

Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy?

TL;DR: While follow-up could be interrupted in patients unfit for surgery due to comorbidities or age, and in SCA stable over time, recent evidences do not support surveillance discontinuation in patients with IPMNs fit for surgery.
Journal ArticleDOI

Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.

TL;DR: Certain new EUS-related techniques, such as searching for DNA abnormalities or protein markers in pancreatic fluid, appear to be promising and there is still limited evidence on the accuracy of imaging procedures used for screening or agreement on which patients to treat.
References
More filters
Journal ArticleDOI

International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

TL;DR: Ovarian-type stroma has been proposed as a requisite to distinguish MCN from IPMN, and some other distinct features to characterize IPMN and MCN have been identified, but there remain ambiguities between the two diseases.
Journal ArticleDOI

Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.

TL;DR: Of tested markers, cyst fluid CEA is the most accurate test available for the diagnosis of mucinous cystic lesions of the pancreas.
Journal ArticleDOI

Increased Risk of Cancer in the Peutz–Jeghers Syndrome

TL;DR: It is suggested that patients with the Peutz-Jeghers syndrome have an increased risk for the development of cancer at gastrointestinal and nongastrointestinal sites.
Related Papers (5)

European evidence-based guidelines on pancreatic cystic neoplasms

Marco Del Chiaro, +88 more
- 01 May 2018 -